حاضر اخوي
طبعا في مصادر كثير جدا و فيديوهات و الارقام جديدة بس كنموذج انا ارسل هنا قليل من مصادر من قبل كم سنة عن الطب في ايران حاليا متطور اكثر بكثير في هذا االمجالات الطبية
و عندهم السياحة الطبية قليل من دول العالم عندها سياحة الطبية بمعني الكلمة
و اظن لو ما كانت ايران منبوذه من دول العربية و الخليج كانوا يقدروا ان يشاركوا مع بعض في كثير من المجالات الطبية
IRANIAN PHARMACEUTICAL MARKET PLAYERS
There are around 100 pharmaceutical manufacturing companies active in Iran with more than 60 plants committed to producing almost 40 billion drug units annually. Since some of the products do not meet International Goods Manufacturing Practice Standards, the Iranian Government has introduced key policy initiatives. Initiatives include promoting R&D and investing in new products, with Iranian pharmaceutical compa- nies developing more than 12 new treatments for diseases including cancer and diabetes. With investment in start-ups active in biotechnology and stem cell research,
Iran has achieved a recognized international status and is ranked among the world’s leading stem-cell research countries. It has also invested heavily in relevant facilities and requisite infrastructure for plasmapheresis (blood
KEY PLAYERS IRAN
There are many successful stock listed pharmaceutical companies in Iran which are profitable. In the diagram below their net profit and profit ratio to sales amount are depicted.
Average ratio of benefit to sales of Iranian pharmaceutical companies in 2014 was approximately 31 percent. The highest ratio was achieved by
Pars Daroo with 52.8 percent and the lowest by
Abooreyhan with 17.4 percent.
مشاهدة المرفق 351661
GROWTH POTENTIAL
The Iranian pharmaceutical market has experienced a 30% increase in sales from 2009 to 2014, which is higher than the average in the region. The Middle-East as a whole has experienced a 8.6% increase, whilst CIS countries experienced a 10.5% average increase rate from 2009 to 2014.
مشاهدة المرفق 351663
مشاهدة المرفق 351664
Compared to many other countries of the region Iran pharmaceutical market could be considered as a large and lucrative market. Iran pharmaceutical market has experienced an almost 6 times increase in market value between 2008 to 2015 (Figure1
References
1. The World Bank. 2016.
http://www.worldbank.org/en/country/iran/overview.